Follow
Research and Development
Research and Development: innovative activities performed by corporations or governments for the creation, discovery and advancement of services and products.
MAR 23, 2022 | 1:00 PM
Date: March 23, 2021 Time: 5:00am (PDT), 8:00am (EDT), 2:00pm (CEDT) Using a global targeted method, this lipidomic approach to meat characterization analyzes over 2000 lipid species in both...
MAR 22, 2022 | 7:00 AM
Date: March 22, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) DNA replication happens at the very early stage of cell development, at such early stages of development...
MAR 16, 2022 | 9:00 AM
Date: March 16, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEDT) With a renewed and growing interest in therapeutic oligonucleotides (oligos) across the pharmaceutical industry, the req...
MAR 16, 2022 | 8:00 AM
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
MAR 16, 2022 | 7:00 AM
Date: March 16, 2022 Time: 07:00am (PDT), 10:00am (EDT), 4:00pm (CEDT) During this webinar, we will provide an overview of the current landscape of sepsis management and the impact of rapid...
MAR 10, 2022 | 11:55 PM
Detection of neural signatures related to pathological behavioral states could enable adaptive deep brain stimulation (DBS), a potential strategy for improving efficacy of DBS for neurologic...
MAR 10, 2022 | 11:55 PM
Alzheimer’s and Parkinson’s diseases (AD, PD) are the two most common neurodegenerative disorders. Despite their debilitating effects and increasing prevalence in our society, no...
MAR 10, 2022 | 11:55 PM
Neuroscience is experiencing an exciting era of integrating novel materials and tools to record neural activity made possible through significant advances in materials science, electrical en...
MAR 10, 2022 | 11:55 PM
Several age-related neurodegenerative disorders are characterized by the deposition of aberrantly folded proteins. The histopathological hallmark of synucleinopathies is the deposition of É‘-...
MAR 10, 2022 | 11:55 PM
Major depression (MDD) is a common psychiatric condition and a leading cause of disability worldwide. While psychotherapy and pharmacotherapy are effective treatments for the majority of peo...
MAR 10, 2022 | 1:30 PM
Neuropore Therapies is discovering and developing novel small molecule disease-modifying therapeutics to treat patients with neurodegenerative diseases, including Parkinson’s disease a...
MAR 10, 2022 | 9:00 AM
There are currently no approved therapeutics to promote neural repair following central nervous system (CNS) damage. Groundbreaking studies in neurotrauma and disease found that a family of...
